Literature DB >> 21603449

Pulmonary hypertension for primary care providers.

Mark A Thompson1, Avery P McKee, Hamang Patel.   

Abstract

Pulmonary hypertension is a constellation of diseases that shares signs and symptoms of dyspnea, fatigue, chest pain, palpitations, and syncope. Research advances made over the past decade have significantly changed the natural history of this disease. Therapies initially designed to specifically target the molecular causes of increased pulmonary vascular resistance are now used in all types of patients with pulmonary hypertension. The challenge of the primary care physician is first, identifying pulmonary hypertension, and second, determining the modifiable substrates that contribute to the development and symptoms of this disease.

Entities:  

Keywords:  Chest pain; dyspnea; pulmonary arterial hypertension; pulmonary hypertension; syncope

Year:  2009        PMID: 21603449      PMCID: PMC3096296     

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  23 in total

1.  Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.

Authors:  L Abenhaim; Y Moride; F Brenot; S Rich; J Benichou; X Kurz; T Higenbottam; C Oakley; E Wouters; M Aubier; G Simonneau; B Bégaud
Journal:  N Engl J Med       Date:  1996-08-29       Impact factor: 91.245

2.  Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.

Authors:  Eric Hachulla; Virginie Gressin; Loïc Guillevin; Patrick Carpentier; Elisabeth Diot; Jean Sibilia; André Kahan; Jean Cabane; Camille Francès; David Launay; Luc Mouthon; Yannick Allanore; Kiet Phong Tiev; Pierre Clerson; Pascal de Groote; Marc Humbert
Journal:  Arthritis Rheum       Date:  2005-12

3.  Proceedings of National Heart, Lung, and Blood Institute pediatric cardiology workshop: pulmonary hypertension.

Authors:  W F Friedman
Journal:  Pediatr Res       Date:  1986-09       Impact factor: 3.756

4.  HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study.

Authors:  M Opravil; M Pechère; R Speich; H I Joller-Jemelka; R Jenni; E W Russi; B Hirschel; R Lüthy
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405

5.  Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients.

Authors:  M Castro; M J Krowka; D R Schroeder; K C Beck; D J Plevak; S R Rettke; D A Cortese; R H Wiesner
Journal:  Mayo Clin Proc       Date:  1996-06       Impact factor: 7.616

6.  ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.

Authors:  Vallerie V McLaughlin; Stephen L Archer; David B Badesch; Robyn J Barst; Harrison W Farber; Jonathan R Lindner; Michael A Mathier; Michael D McGoon; Myung H Park; Robert S Rosenson; Lewis J Rubin; Victor F Tapson; John Varga
Journal:  J Am Coll Cardiol       Date:  2009-04-28       Impact factor: 24.094

7.  Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

Authors:  G E D'Alonzo; R J Barst; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; J T Kernis
Journal:  Ann Intern Med       Date:  1991-09-01       Impact factor: 25.391

8.  Survival in primary pulmonary hypertension. Validation of a prognostic equation.

Authors:  J Sandoval; O Bauerle; A Palomar; A Gómez; M L Martínez-Guerra; M Beltrán; M L Guerrero
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

9.  Primary pulmonary hypertension. A national prospective study.

Authors:  S Rich; D R Dantzker; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; S K Koerner
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

Review 10.  Updated evidence-based treatment algorithm in pulmonary arterial hypertension.

Authors:  Robyn J Barst; J Simon R Gibbs; Hossein A Ghofrani; Marius M Hoeper; Vallerie V McLaughlin; Lewis J Rubin; Olivier Sitbon; Victor F Tapson; Nazzareno Galiè
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.